Retatru and Cagrilintide - 12.5mg/2.5mg - Research Peptide (compare to Retatrutide)
- SKU:
- Reta/Cag 12.5MG/2.5MG
- Weight:
- 2.00 Ounces
Description
Description
CAS Number: N/A (research blend)
Molecular Formula: N/A (research blend)
Molecular Weight: N/A (research blend)
Form: Lyophilized Powder
Quantity: 12.5mg/2.5mg vial
Purity: ≥ 98% (HPLC Verified)
Dosing Information
Retatru is typically administered once weekly via subcutaneous injection, with doses ranging from 1 mg to 12 mg depending on clinical indication and patient response.
For obesity treatment, dose escalation protocols starting at lower doses (e.g., 2 mg) and gradually increasing to maintenance doses (e.g., 4 mg, 8 mg, or 12 mg) have been studied
Link below for more detailed information:
Product Overview:
Retatru/Cagrilintide (12.5mg/2.5mg) is a dual-compound research peptide combining Retatru, a novel multi-agonist peptide with activity across GLP-1, GIP, and glucagon pathways, and Cagrilintide, an amylin analog. Together, these compounds form a unique research model for studying synergistic mechanisms in appetite regulation, energy expenditure, and metabolic signaling.
This formulation offers researchers the ability to investigate interactions between incretin-based peptides and amylin mimetics in controlled laboratory settings.
Applications in Research:
-
Studies into metabolic regulation and weight management models
-
Appetite suppression and satiety pathway investigations
-
Research on energy balance and glucose homeostasis
-
Exploration of synergistic effects between incretin mimetics and amylin analogs
Storage & Handling:
-
Store lyophilized peptide at -20°C, protected from light and moisture.
-
Reconstitute using sterile bacteriostatic water under aseptic lab conditions.
-
Once reconstituted, store refrigerated and use within appropriate timeframes.
-
Avoid repeated freeze-thaw cycles.
⚠️ Research Use Only – Legal Disclaimer
All products on this site are for research and development use only. Products are not for human consumption of any kind. The statements made on this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure, or prevent any disease.
Biogenic Foods, LLC is a chemical supplier. Biogenic Foods is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act. Biogenic Foods is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic Act.
All products are sold for research, laboratory, or analytical purposes only, and are not for human consumption.